Résumé
Le but de cet aperçu est d'examiner dans quelles directions se sont réalisés les progrès actuels de la pathogénie des tumeurs, notamment de la carcinogénèse dans ses différentes manifestations. Il traite aussi des facteurs génétiques, hormonaux et d'autres facteurs intrinsèques, influençant le développement des tumeurs, et de quelquesuns des principes fondamentaux de transformation néoplastique y inclus le rôle des virus.
References
V. Ellermann andO. Bang, Zbl. Bakteriol.I. Orig. 46, 595 (1908). (Quoted byC. Oberling andM. Guerin, Adv. Cancer Res.2, 351 [1954]).
L. Gross, Proc. Soc. exp. Biol. Med.76, 27 (1951); Brit. med. J., ii, 1 (1958).
C. Friend, J. exp. Med.105, 307 (1957).
S. E. Stewart, B. E. Eddy, A. M. Gochenour, N. G. Borgese, andG. E. Grubbs, Virology3, 380 (1957).
A. Graffi, Ann. N. Y. Acad. Sci68, 540 (1957).
Jackson Memorial Laboratory Staff, Science78, 465 (1933).
P. Rous, J. exp. Med.13, 353 (1911); The Harvey Lectures31, 71, (1935–1936).
R. E. Shope, J. exp. Med.58, 607 (1933).
J. Furth andD. Metcalf, J. chron. Dis.8, 88 (1958).
Various Authors,Genetic Concepts for the Origin of Cancer (L. C. Strong, Ed.), Ann. N. Y. Acad. Sci.71, 807 (1958).
J. W. Cook, G. A. D. Haslewood, C. L. Hewett, I. Hieger, E. L. Kennaway, andW. V. Mayneord, 2nd Internat. Cancer Congr. (Brussels 1936),I (Reports), 1.
P. Shubik andJ. L. Hartwell,Survey of Compounds which have Been Tested for Carcinogenic Activity, Suppl. 1 (U. S. Dept. Hlth., Educ. & Welfare, 1957).
J. A. Hendry, R. F. Homer, F. L. Rose, andA. L. Walpole, Brit. J. Pharmacol.6, 235 (1951).
W. C. Hueper, A. M. A. Arch. Path.58, 360, 475, 645 (1954).
M. H. Salaman andF. J. C. Roe, Brit. J. Cancer7, 472 (1953).
A. Pullman andB. Pullman, Adv. Cancer Res.3, 117 (1955);A. Lacassagne, N. P. Buu-Hoi, R. Daudel, andF. Zajdela, Adv. Cancer Res.4, 315 (1956).
L. Young, Biochem. Soc. Symp. (Cambridge Univ. Press)5, 27, (1950).
P. M. Bhargava andC. Heidelberger, J. Amer. chem. Soc.78, 3671 (1956).
J. A. Miller andE. C. Miller, Adv. Cancer Res.1, 339 (1953).
V. T. Oliverio andC. Heidelberger, Cancer Res.18, 1094 (1958).
E. K. Weisburger andJ. H. Weisburger, Adv. Cancer Res.5, 331 (1958).
S. Rogers, J. exp. Med.105, 279 (1957).
I. Berenblum, Acta Unio Internat. Cancrum15, 22 (1959).
P. Alexander, Adv. Cancer Res.2, 1 (1954).
A. Haddow, Ann. Rev. Biochem.24, 689 (1955).
I. Berenblum, Ann. Roy. Coll. Surg., England21, 339 (1957).
H. S. Kaplan, Cancer Res.14, 535 (1954).
F. Bielschowsky andE. S. Horning, Brit. med. Bull.14, 106 (1958).
A. M. Brues, Adv. Cancer Res.2, 177 (1954).
M. S. Biskind andG. S. Biskind, Proc. Soc. exp. Biol. Med.55, 176 (1944).
J. Furth, A. C. Upton, andA. W. Kimball, Radiation Res., Suppl.1, 243 (1959).
L. Foulds, Ann. Roy. Coll. Surg., England9 93 (1951); Cancer Res.14, 327 (1953); J. Chron. Dis.8, 2 (1958);J. Furth, Cancer Res.13, 477 (1953).
F. M. Burnet, Acta Unio Internat. Cancrum 15, 31 (1959).
J. P. Greenstein,Biochemistry of Cancer, 2nd Ed. (Academic Press, New York 1952).
H. N. Green, Brit. med. Bull.14, 101 (1958).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berenblum, I. Advances in tumour pathogenesis. Experientia 15, 285–289 (1959). https://doi.org/10.1007/BF02158528
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02158528